Copyright © 2021. Inderes Oyj. All rights reserved.

CellaVision

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
27.7.
2022

On July 27, 2022, CellaVision® announces the launch of DIFF-Line ™ by CellaVision, a new workflow solution for low-volume hematology laboratories, at the AACC convention in Chicago.

DIFF-Line ™ by CellaVision consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision® DC-1, RAL® SmearBox, and RAL® StainBox.

Tiedotteet
20.7.
2022

April 1-June 30, 2022

Tiedotteet
6.7.
2022

CellaVision AB (publ) will publish the Interim report for the second quarter, on July 20, 2022 at 7:20 CEST. The report will be available at ir.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CEST where
Simon Østergaard, President & CEO, will present and comment the report.

Tiedotteet
20.5.
2022

CellaVision invites institutional investors, financial analysts and media to join its Capital Markets Day on June 16, 2022.

During the event, CellaVision’s executive management will present the next exciting phase of our strategic vision: The Power of Focus – Enhancing the Future of Microscopy.

Join us for an update on our operational priorities and focused insights on new growth opportunities over the next five years.

Tiedotteet
11.5.
2022

The following resolutions were passed at the Annual General Meeting (the “AGM”) of CellaVision AB (publ) (“CellaVision”) on 11 May 2022 in Lund.

Tiedotteet
10.5.
2022

Organic sales growth:
Q1, 2022: 15% (7)

EBITDA margin:
Q1, 2022: 36% (34)

1 January-31 March 2022

Tiedotteet
26.4.
2022

CellaVision AB (publ) will publish the Interim report for the first quarter, on May 10, 2022 at 7:20 CEST. The report will be available at www.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CEST where Simon Østergaard, President & CEO, will present and comment the report.

Tiedotteet
25.4.
2022

CellaVision will host a Capital Markets Day on June 16, 2022. During the day, executive management will present the company’s updated strategic direction, which aims to develop and broaden the company’s operations over the next five years. The event is planned to be held at CellaVision head quarter in Lund. Invitation will be sent out closer to the event.

Tiedotteet
19.4.
2022

Today, CellaVision announced that the company's Annual and Sustainability Report for 2021 is available as PDF at www.cellavision.com and can be read via the link below.

The company has decided to print the 2021 Annual and Sustainability Report in a small number of copies in accordance with the company's environmental policy. To request a printed version, please visit the investor pages at CellaVision's website.

Tiedotteet
6.4.
2022

The shareholders of CellaVision AB (publ) reg. no. 556500-0998 (the “Company”) are hereby given notice of the Annual General Meeting (the “AGM”) on 11 May 2022 at 15.00 CEST in CellaVision’s premises at Mobilvägen 12 in Lund. Voting registration starts at 14.30 CEST and continues until the opening of the AGM.

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail.

Right to participate

CellaVision